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Summary: A six month prospective study was carried out in a surgical 
intensive care unit (SICU) of a university hospital to assess the incidence 
and routes of exogenous colonization by Staphylococcus aureus. A total of 
157 patients were included in the study. One thousand one hundred and 
eleven specimens (nasal, surgical wound swabs, tracheal secretions obtained 
on admission and once a week thereafter, and all clinical specimens) were 
collected over a four month period from patients without nasal de- 
contamination (A). They were compared with 729 specimens collected over 
a two month period from patients treated with nasal mupirocin ointment (B). 
All S. aureus strains were typed by restriction fragment length polymorphism 
(RFLP) pulsed-field gel electrophoresis after SmaI macrorestriction. The 
nasal colonization rates on admission were 25.5 and 32.7% in groups A and 
B, respectively. Thirty-one untreated patients (31.3%) and three patients 
(5.1%) treated with nasal ointment, acquired the nasal S. aureuS in the 
SICU (P=O.O0027). Nasal carriers were more frequently colonized in the 
bronchopulmonary tract (Bp) and surgical wound (SW) (62%) than patients 
who were not nasal carriers (14%) (P<O.OOOOl). The patterns were identical 
for nasal, Bp and SW strains from the same patient. RFLP analysis char- 
acterized seven epidemic strains of methicillin-resistant S. aureus (MRSA) 
which colonized 60% of group A and 9% of group B patients (P<O.OOOOl). 
The bronchopulmonary tract infection rate was reduced in group B (P= 
0.032). In conclusion, in an SICU, nasal carriage of S. aureus appeared to 
be the source of endogenous and cross-colonization. The use of nasal 
mupirocin ointment reduced the incidence of Bp and SW colonization, as 
well as the MRSA infection rate. 
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Introduction 
It is now clear that methicillin-resistant strains of Staphylococcus aureus 
are as pathogenic as methicillin-sensitive strains.’ Severe staphylococcal 
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infections are an increasing problem, particularly in intensive care and 
burns units’ where methicillin-resistant S. aureus (MRSA) are responsible 
for 30-60% of such infections.3” In our university hospital, MRSA col- 
onization is endemic, with grouped cases and sudden onset, suggesting 
cross-colonization.3~4~@ MRSA-induced morbidity and mortality,’ first ob- 
served in Europe, are now widespread in many countries (Australia, America 
and Africa).‘&12 Nasal carriage is the principal endogenous reservoir for 
infection of patients in surgical wards, as demonstrated by phage typing,’ 
and patients with chronic renal failure on maintenance haemodialysis.‘3 
Nasal mupirocin in these patients leads to total eradication of S. aureus 
nasal carriage, a 4*26-fold reduction in the incidence of bacteraemia and a 
substantial cost saving.” Detection and treatment of nasal carriers with 
intranasal mupirocin, associated with other measures contributed to the 
control of large epidemic of MRSA.‘6”7 Hospitalization in a surgical intens- 
ive care unit (SICU) is associated with numerous risk factors for infection 
with S. aureus, i.e. the number of care procedures, proximity of colonized/ 
infected patients, presence of foreign materials and surgical wounds, and 
lengthy antibiotic therapy.““’ Tracheal tubes and surgical wounds, as well 
as staff and patients’ nares, are frequently colonized and are thus potential 
reservoirs for cross-infection.‘4,2+23 With the advent of molecular biology, 
several, highly discriminatory techniques, based on DNA polymorphism, 
have been developed for strain comparisons in epidemiological studies.2”26 
As a result, the incidence of cross-colonization can now be evaluated 
accurately by genotyping methods. This six month prospective study was 
performed to assess the incidence and routes of exogenous colonization and 
hospital-acquired infections caused by 5’. aureus, and to evaluate the efficacy 
of nasal mupirocin ointment in reducing cross-colonization in a SICU. 
Materials and methods 
Study design 
In a two-step prospective study, a total of 1740 specimens, collected from 
157 patients admitted to the SICU (15 beds) of the University Hospital of 
Besancon, France, were screened for the presence of S. aureus. Nasal and 
surgical wound swabs and tracheal secretions were collected on admission 
and once a week during hospitalization in the SICU, together with all 
clinical specimens. Over a four month period 1011 specimens were collected 
from patients without nasal decontamination (A). During the second period, 
729 specimens were collected over a two month period from patients treated 
with nasal mupirocin ointment (B). All S. aureus strains were typed. Nasal 
ointment was applied twice a day in each nostril for the first week, beginning 
on the day of admission and continuing whatever the screening results. 
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Bacteriological techniques 
Specimens were cultured using standard blood agar (blood agar base + 7% 
horse blood) and Chapman agar (both freshly prepared). Plates were 
incubated in air at 37°C for 48 h. S. aureus was identified by colony 
morphology and by the slide and tube coagulase tests. Methicillin sensitivity 
was checked at 30°C by the conventional Kirby-Bauer disc-diffusion 
method. 
Epidemiologic genotyping 
Unsheared DNA was prepared by the method of Prevost et a1.,27 digested 
with the restriction endonuclease SmaI according to the manufacturer’s 
instructions and subjected to pulsed-field gel electrophoresis (PFGE) using 
the CHEF-DRII system (BioRad Ltd) (pulse times of 20 s for 12 h and 
then 5-15 s for 17 h at 150 V and 14OC). Gels were stained with ethidium 
bromide (0.1%) for 30 min. 
Analysis of DNA relatedness 
The electrophoretic restriction patterns (number and size of fragments) 
were analysed by scanning photographic negatives with a LKB 2222- 
020 Ultrascan laser densitometer (LKB Pharmacia, Uppsala, Sweden) as 
described by PrCvost et aZ.27 The restriction pattern of each strain was 
compared to the profile of all other strains. The DNA fingerprint of each 
isolate was scored for the presence or absence of individual bands (negative 
character: absence of a band; positive character: presence of a band). A 
similarity index was determined for each pair of strains by the Jaccard- 
Sneath formula: SQJ1 = N,I(N, + Nb),28 where N, is the number of characters 
shared by i and j, and Nb the number of different characters. We compared 
intergel restriction fragment length polymorphisms (RFLPs) by including 
an internal reference strain in each gel. Major restriction genotypes were 
defined according to Struelens et aZ29 (common restriction patterns differed 
by three or fewer fragments and showed a similarity coefficient >85%). 
Major genotypes were labelled by numerals, and each of their variant 
subtypes was indicated by a letter suffix. 
DeJinition of cases 
Case definitions were based on Centers for Disease Control (CDC) criteria.30 
A case of colonization was defined as any patient with a culture positive 
for S. aureus without evidence of tissue invasion. 
Statisical analysis 
The two-sided x2 test and the Fisher’s exact two-sided test were used for 
contingence univariate analysis on a computer Epi-Info 5.01. 
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Figure 1. Pulsed-field gel electrophoresis of DruI digested DNA from StaphyZococcus aweus 
isolates. Lane 1: pattern 50; lanes 2 and 3: pattern 4a; lane 4: pattern 51; lane 5: pattern 
52; lanes 6 and 7: pattern 47; lane 8: pattern 35; lane 9: pattern 53; lane 10: pattern 4b. 
Results 
One hundred and fifty non-repetitive MRSA and methicillin-sensitive S. 
aureu~ (MSSA) strains showed 65 distinct major DNA patterns (Figure 1). 
Eleven variant subtypes (types 4a-k) clustered in a clonal group of patterns 
accounting for 59 isolates. Three other major patterns could be subdivided 
into types (types 9a-c, lla-b and 55a-b). Sixty-one other major patterns 
clustered at less than 85% similarity. 
The nasal colonization rates on admission were respectively 25.5% (22 
patients) and 32.7% (19 patients) in periods A and B (P>O*O5). 31.3% of 
patients (n=31) vs only 5.1% (n=3) acquired the nasal S. aureus in the 
SICU [P<O*OOO27; RR = 6.05 (1.94-l 8*93)]. The prevalence of MRSA/ 
MSSA among nasal isolates was 35/18 and 6/16 in the first and second 
periods [P= O-0048; RR = 2.42 (1 *19+92)]. 
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Table I. Nasal colonization by epidt mic strains 
Methicillin-sensitive Methicillin-resistant 
No. of No. of 
colonized patients colonized patients 
No. RFLP On SICU- No. RFLP On SICU- 
admission acquired admission acquired 
ii 2 1 0 
: 
; 0* 1 ; 
37 
i 2 
4 13 
48 0 4 0 
272 2 0 1 
32 : 1 
Total number of 7 2 13 21 
patients 
* Pattern present in one patient at the beginning of the study. 
RFLP, restriction fragment length polymorphism. 
SICU, surgical intensive care unit. 
Over the six months of this study, 13 patients were colonized with an 
MRSA on admission to the SICU and 28 paients had an MSSA; 28 patients 
acquired an MRSA in the SICU and six patients acquired an MSSA 
[P<O*OOOl ; RR = 2.60 (1.61-4.1 S)]. Genomic analysis characterized 30 dif- 
ferent patterns isolated from single patients and 11 patterns isolated from 
several patients. As shown in Table I, most, epidemic strains were MRSA 
before SICU admission as in the SICU and MSSA were sporadic strains. 
Seven MRSA strains colonized 60% of nasal carriers in group A and 9% 
in group B [P=O.OOOl; RR=6.64 (l-74-25*35)]. 
During the two study periods, S. aureus colonized various other sites in 
54 patients. Among the 75 nasal carriers, 42 were also colonized at another 
site, as were 12 patients among the 82 who were not nasal carriers [P<O*OOOl; 
RR=3*83 (2*19-6*70)]. Table II h s ows the distribution of colonized sites. 
Two, the bronchopulmonary tract and surgical wounds, were colonized by 
the nasal strain of the same patient (P<O*OOOl and P=O*OO9, respectively). 
The three major SICU-acquired patterns (1, 2 and 4a) occurred con- 
secutively during the first period. Among 17 patients with nasal colonization 
by a pattern 4a strain, four were carriers on admission: one in February 
(index case), one in March, one in May (period A) and one in June (period 
B). Thirteen patients acquired nasal colonization with this pattern in the 
SICU and three patients acquired it at another site without nasal col- 
onization. The epidemic curve (Figure 2) shows that cross-colonization in 
the SICU was very frequent during period A (12 patients) and was rapidly 
reduced during period B (only one case, at the beginning of period B). In 
period B, bronchopulmonary tract colonization persisted in three patients, 
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Table II. Distribution of Staphylococcus aureus-positive sites 
Specimen No. (%) of patients Nasal colonization 
with positive 
cultures Positive with Negative or 
(n=160) the same strain positive with 
another strain 
Tracheal secretion 
Surgical wound 
swab 
Blood Vascular line 
Urine 
Rectal swab 
43 (268) 28 1.5 <0~0001 
12 (7.5) 9 ‘32b3089’ 
(i-18) 
9 (5.6) 4 5 3 1 : ii: 
5 (3.1) ; 
1 (0.6) 1 i 2 
NS, non-significant. 
” 
Feb Mar APT May Jun Jul 
Mupirocin 
ointment 
Aw SOP 
Figure 2. Epidemic curve of 4a pattern. (a), Nasal carriage; (a), other sites of colonization; 
(m), nasal carriage and other sites of colonization. I, Incidence; P, prevalence. 
one with simultaneous nasal colonization. All the strains isolated during both 
period A and period B were susceptible to mupirocin (CMI<O*25 mg 1-j). 
During the study period, we observed no acquired methicillin resistance. 
Seven patients initially colonized with an MSSA pattern acquired an MRSA 
with a different pattern in the SICU. Nineteen patients developed an 
infection with an S. aureus strain during period A and four during period 
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Table III. Infections 
45 
Infections Period A Period B P 
Pulmonary tract 
Bacteraemia/septicaemia 
Surgical wound 
Urinary tract 
Surface 
Vascular line 
NS, non-significant. 
13 
: 
0.032 
i 
NS 
0 
2 E 
1 : NS 
1 0 NS 
B [P=O*O36; RR= 2.78 (l*OO-7*78)]. The incidence of infections was 28 
per 100 patients admitted (n = 25) before decontamination and 6.8 during 
the treatment period (n=4) [P=O*OOOl; RR=4*0 (l-83-8*73)]. The two 
major infections (Table III) were pneumonia and bacteraemia/septicaemia, 
and both were reduced during period B, the first significantly (P=O*O32). 
Discussion 
The epidemiology and routes of MRSA transmission must be identified, 
in order to control the spread by means of specific measures.31 Accurate 
epidemiologic typing is of primary importance. Markers include the ly- 
sotype, serotype and capsular type. Molecular subtyping methods include 
protein electrophoretyping,32 plasmid content and plasmid DNA restriction 
pattern, 33~34 restriction analysis of total genomic DNA3’ and RFLP generated 
by Southern hybridization with DNA probes.34,35 Recently, DNA finger- 
printing by PFGE has provided a higher level of strain discrimination.26’36 
This method is more effective than ribotyping37 and polymerase chain 
reaction genome fingerprinting25 in distinguishing between MRSA isolates. 
The use of a highly discriminant typing method confirmed that the major 
vector of MRSA infections in the SICU is cross-colonization and not the 
selection of resistant mutants of susceptible strains, despite the frequent 
use of p-lactam antibiotics.7’38 This method also showed that, during period 
A, the situation was ‘pseudo-endemic’, as the stable high rate of colonization 
was due to the successive spread of different epidemic patterns. The staff 
can be the reservoir for epidemic spread of MRSA’4,29,40 but this was not 
the case in our study, as three different strains followed one another 
during A, and only patient decontamination alone was successful during 
B. Transient hand carriage during the numerous patient care procedures, 
especially during bronchopulmonary tract and surgical wound care, was 
probably the source of cross-colonization by a strain with the same DNA 
pattern. 
RFLP PFGE was used for the first time to compare isolates from the 
nose and other sites. This comparison, with a very effective typing method, 
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allowed us to carry out an accurate study of MRSA epidemiology. Col- 
onization of the bronchopulmonary tract before nasal colonization was also 
found by Walsh et al.” but we demonstrated that the DNA pattern of the 
bronchopulmonary strains were identical to that of the nasal strains. 
Mupirocin ointment applied to the anterior nostrils was very effective 
in eradicating S. aureus nasal carriage (P=O.O0027) as previously sug- 
gested.‘7’414 Nasal decontamination, which has been used with varying 
degrees of success in several outbreaks,‘6’4547 significantly reduced the rate 
of infections and the incidence of pneumonia due to MRSA and MSSA. 
The three ventilated patients who acquired nasal colonization during period 
B carried the same strain in the bronchopulmonary tract, and all three 
strains were mupirocin-susceptible. The presence of the ventilator tube 
probably explains the recolonization of the nares without selection of 
mupirocin-resistant strains.48’49 
Detailed guidelines for the control of epidemic MRSA have been pub- 
lished by the British Society of Antimicrobial Chemotherapy and the 
Hospital Infection Society. These guidelines emphasize the importance of 
isolating positive patients, staff hand disinfection, and eliminating skin and 
nasal carriage. Routine nasal decontamination on admission was effective 
in reducing colonization and infection rates without screening, isolation 
measures and skin disinfection. Such a strategy can be used in a single 
small unit like ours (15 beds) but is more problematic for an entire 
hospital. The use of mupirocin alone to treat nasal colonized patients delays 
decontamination and requires strict isolation of patients until clearance 
swabs have proved negative. 
Conclusions 
Nasal carriage appears to be the major source of endogenous and cross- 
colonization in the SICU. The use of mupirocin nasal ointment reduces 
the incidence of both colonization and infection. Routine identification 
and decontamination of nasal carriers on admission, especially after 
transfer from other units, can probably avoid the spread of S. aweus 
epidemics. 
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